Ann: Strategic Plan & Asset Review, WoundVue, page-18

The "re-focussing" to one main project is probably a good thing given the rate of expenditure the company had. One of the points made was sales to kick in in 2018 (said before though) and breakeven by 2020. That is the sort of stuff we want to hear. But APAS is going to have to move off the shelves pretty well to get to the B/E point in less than 3 years so that will be a big marketing effort. I'd like to have seen someone address how the company was going to get to 2020 and what direction will the company take with respect to the next gen of their technology. GLTA